Quantitative fluorescent intensities demonstrated that the levels of RET were 1.5–2.0 times higher in Parkinson’s disease with combined delivery than Parkinson’s disease controls while they were 0.27–0.71 times lower following delivery to the putamen alone (Fig. 6M). Here, RET is linked to Parkinson disease.